GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » KalVista Pharmaceuticals Inc (FRA:4XC1) » Definitions » Pretax Margin %

KalVista Pharmaceuticals (FRA:4XC1) Pretax Margin % : % (As of Jul. 2024)


View and export this data going back to 2016. Start your Free Trial

What is KalVista Pharmaceuticals Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. KalVista Pharmaceuticals's Pre-Tax Income for the three months ended in Jul. 2024 was €-37.29 Mil. KalVista Pharmaceuticals's Revenue for the three months ended in Jul. 2024 was €0.00 Mil. Therefore, KalVista Pharmaceuticals's pretax margin for the quarter that ended in Jul. 2024 was %.

The historical rank and industry rank for KalVista Pharmaceuticals's Pretax Margin % or its related term are showing as below:


FRA:4XC1's Pretax Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -153.96
* Ranked among companies with meaningful Pretax Margin % only.

KalVista Pharmaceuticals Pretax Margin % Historical Data

The historical data trend for KalVista Pharmaceuticals's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

KalVista Pharmaceuticals Pretax Margin % Chart

KalVista Pharmaceuticals Annual Data
Trend Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -230.42 - - - -

KalVista Pharmaceuticals Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of KalVista Pharmaceuticals's Pretax Margin %

For the Biotechnology subindustry, KalVista Pharmaceuticals's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


KalVista Pharmaceuticals's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, KalVista Pharmaceuticals's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where KalVista Pharmaceuticals's Pretax Margin % falls into.



KalVista Pharmaceuticals Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

KalVista Pharmaceuticals's Pretax Margin for the fiscal year that ended in Apr. 2024 is calculated as

Pretax Margin=Pre-Tax Income (A: Apr. 2024 )/Revenue (A: Apr. 2024 )
=-118.032/0
= %

KalVista Pharmaceuticals's Pretax Margin for the quarter that ended in Jul. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Jul. 2024 )/Revenue (Q: Jul. 2024 )
=-37.288/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


KalVista Pharmaceuticals  (FRA:4XC1) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


KalVista Pharmaceuticals Pretax Margin % Related Terms

Thank you for viewing the detailed overview of KalVista Pharmaceuticals's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


KalVista Pharmaceuticals Business Description

Traded in Other Exchanges
Address
55 Cambridge Parkway, Suite 901 East, Cambridge, MA, USA, 02142
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States.

KalVista Pharmaceuticals Headlines

No Headlines